187 related articles for article (PubMed ID: 34213673)
1. Platelet distribution width is highly associated with thrombotic events in primary antiphospholipid syndrome.
Shi Y; Jiang H; Huang C; Hu C; Zhao J; Li M; Zeng X
Clin Rheumatol; 2021 Nov; 40(11):4581-4588. PubMed ID: 34213673
[TBL] [Abstract][Full Text] [Related]
2. The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome.
Rupa-Matysek J; Gil L; Wojtasińska E; Ciepłuch K; Lewandowska M; Komarnicki M
Rheumatol Int; 2014 Nov; 34(11):1599-605. PubMed ID: 24671503
[TBL] [Abstract][Full Text] [Related]
3. Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?
Korkmaz S; Uslu AU; Sahin S; Senel S; Sencan M
Platelets; 2014; 25(5):343-7. PubMed ID: 23971949
[TBL] [Abstract][Full Text] [Related]
4. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Plasma-Derived Small Extracellular Vesicles Indicates Ongoing Endothelial and Platelet Activation in Patients with Thrombotic Antiphospholipid Syndrome.
Štok U; Blokar E; Lenassi M; Holcar M; Frank-Bertoncelj M; Erman A; Resnik N; Sodin-Šemrl S; Čučnik S; Pirkmajer KP; Ambrožič A; Žigon P
Cells; 2020 May; 9(5):. PubMed ID: 32414170
[TBL] [Abstract][Full Text] [Related]
9. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
10. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
Nascimento IS; Radin M; Gândara APR; Sciascia S; de Andrade DCO
Lupus; 2020 Jun; 29(7):676-685. PubMed ID: 32279584
[TBL] [Abstract][Full Text] [Related]
11. Platelet volume indices correlate to severity of heart failure and have prognostic value for both cardiac and thrombotic events in patients with congenital heart disease.
Sato M; Asagai S; Harada G; Shimada E; Inai K
Heart Vessels; 2022 Dec; 37(12):2107-2118. PubMed ID: 35761122
[TBL] [Abstract][Full Text] [Related]
12. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus.
Jiménez S; Tàssies D; Espinosa G; García-Criado A; Plaza J; Monteagudo J; Cervera R; Reverter JC
Ann Rheum Dis; 2008 Jun; 67(6):835-40. PubMed ID: 17728329
[TBL] [Abstract][Full Text] [Related]
13. Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity.
Pyo JY; Jung SM; Lee SW; Song JJ; Lee SK; Park YB
Yonsei Med J; 2017 Nov; 58(6):1128-1134. PubMed ID: 29047236
[TBL] [Abstract][Full Text] [Related]
14. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.
Erkan D; Yazici Y; Peterson MG; Sammaritano L; Lockshin MD
Rheumatology (Oxford); 2002 Aug; 41(8):924-9. PubMed ID: 12154210
[TBL] [Abstract][Full Text] [Related]
16. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
17. [Classification and clinical analysis of 165 patients with antiphospholipid syndrome.].
Xu N; Zhang Y; Zhang W; Zhao Y; Zeng XF
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):904-7. PubMed ID: 20079318
[TBL] [Abstract][Full Text] [Related]
18. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
[TBL] [Abstract][Full Text] [Related]
19. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
